Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01242800 · ClinicalTrials.gov registry record · NA
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
A NA study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- NA
- Development phase
- 390
- Enrollment target
NCT01242800: Completed NA study, sponsored by Eastern Cooperative Oncology Group.
NCT01242800 is a NA study that has completed, run by Eastern Cooperative Oncology Group. The registered enrollment target is 390 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01242800, a NA study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 390 participants
- Enrollment target
Study Summary
RATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of benefit. PURPOSE: This randomized phase III trial is studying early surgery to see how well it works compared to standard palliative therapy in treating patients with stage IV breast cancer.
Primary Outcome
Overall survival (OS) was defined as time from randomization to death from any cause. All patients will be followed for survival through 5 years. Cases with incomplete follow-up or without record of vital status will be censored at the date of last contact. 3-year OS rate was estimated using Kaplan-Meier method.
Interventions
- PROCEDURE therapeutic conventional surgery
- RADIATION radiation therapy
- PROCEDURE palliative surgery
- RADIATION palliative radiation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 390 participants |
| Start Date | 2011-05-16 |
| Est. Completion | 2022-12-21 |
| Phase | NA |
What the finished NCT01242800 record still lists
NCT01242800 is an interventional study that assigns participants to a tested intervention. The registered 390 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 4 interventions - of which therapeutic conventional surgery is the first listed.
NCT01242800 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01242800 about?
NCT01242800 is a clinical study titled "Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer". RATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of benefit. PURPOSE: This randomized phase III trial is studying early surgery to see how well it works compared to standard pa...
What is the current status of trial NCT01242800?
This trial is currently completed. It is a NA study. The enrollment target is 390 participants. The study started on 2011-05-16. Estimated completion is 2022-12-21.
What interventions are being tested in trial NCT01242800?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), radiation therapy (RADIATION), palliative surgery (PROCEDURE), palliative radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT01242800?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01242800's enrollment target sits among peer trials
390 269th of 2000 higher than 1,731 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00397111 · 390 participants
Development of Magnetic Resonance Imaging Techniques for Studying Mood and Anxiety Disorders
- NCT05335928 · 390 participants · Phase 3
Abatacept in Immune Checkpoint Inhibitor Myocarditis
- NCT05445960 · 390 participants · NA
Correlation Between Intraoperative Tourniquet Use and Limb pH, Functional Measures and Patient-reported Outcomes After Ankle Fracture Surgery
- NCT05997615 · 390 participants · Phase 1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI